⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for urologic neoplasms

Every month we try and update this database with for urologic neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerNCT00151034
Urologic Neopla...
Trastuzumab
Paclitaxel
Carboplatin
Gemcitabine
18 Years - University of Michigan Rogel Cancer Center
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.NCT01398306
Carcinoma
Carcinoma, Rena...
Neuroendocrine ...
Carcinoid Tumor
Pancreatic Isle...
Blood sampling ...
18 Years - University Medical Center Groningen
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoNCT05874921
Urothelial Carc...
Urothelial Carc...
Urothelial Carc...
Urothelial Carc...
Urothelial Canc...
Urothelial Carc...
Carcinoma, Tran...
Transitional Ce...
Jelmyto (mitomy...
18 Years - UroGen Pharma Ltd.
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaNCT02386111
Carcinoma, Rena...
Kidney Diseases
Kidney Neoplasm...
Urogenital Neop...
Urologic Diseas...
Urologic Neopla...
Neoplasms
Neoplasms by Hi...
Clear-cell Meta...
Combination of ...
18 Years - Celldex Therapeutics
A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the UrotheliumNCT00035061
Urologic Neopla...
Metastases, Neo...
pemetrexed
18 Years - Eli Lilly and Company
Renal Cell Carcinoma Microenvironment Discovery ProjectNCT04005183
Renal Cell Carc...
18 Years - University Health Network, Toronto
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder CancerNCT05241340
Urothelial Carc...
Sasanlimab
Stereotactic Bo...
Radical Cystect...
18 Years - The Methodist Hospital Research Institute
LPN in Patients With High-complex Renal TumorsNCT04933604
Renal Cancer
Renal Neoplasm
Renal Cell Carc...
Surgery
Oncology
Kidney Ischemia
Kidney Injury
Urologic Neopla...
Urologic Cancer
Kidney Neoplasm...
laparoscopic pa...
Laparoscopic ra...
18 Years - 80 YearsSamsun Liv Hospital
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate CancerNCT00226954
Urologic Neopla...
zoledronic acid
18 Years - Stanford University
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder CancerNCT01200992
Bladder Neoplas...
Neoplasm Recurr...
Transitional Ce...
Carcinoma in Si...
Mycobacterium
EN3348
Mitomycin C
18 Years - Bioniche Life Sciences Inc.
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsNCT04579380
Uterine Neoplas...
Uterine Cervica...
Biliary Tract N...
Urologic Neopla...
Carcinoma, Non-...
HER2 Mutations ...
tucatinib
trastuzumab
fulvestrant
18 Years - Seagen Inc.
Savolitinib vs. Sunitinib in MET-driven PRCC.NCT03091192
Carcinoma
Carcinoma, Rena...
Kidney Neoplasm...
Urologic Neopla...
Kidney Diseases
Neoplasms by Si...
Enzyme Inhibito...
Protein Kinase ...
Savolitinib
Sunitinib
18 Years - 130 YearsAstraZeneca
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenNCT00191971
Urologic Neopla...
Carcinoma, Tran...
Gemcitabine
20 Years - 74 YearsEli Lilly and Company
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryNCT03010813
Colorectal Neop...
Urologic Neopla...
Urologic Diseas...
Nasopharyngeal ...
Oropharyngeal N...
Oral Neoplasms
Hypopharyngeal ...
Laryngeal Neopl...
ENT Diseases
Robotic single ...
18 Years - Chinese University of Hong Kong
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial NephrectomyNCT05887245
Renal Cell Carc...
Kidney Neoplasm
Urologic Neopla...
Urogenital Neop...
Kidney Diseases
18 Years - Centre of Postgraduate Medical Education
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerNCT00384891
Urinary Bladder...
Urinary Bladder...
Urinary Bladder...
Malignant Tumor...
Urologic Diseas...
Urologic Neopla...
Neoplasms
Neoplasms by Si...
Synergo + MMC
Bacillus Calmet...
18 Years - Medical Enterprises Europe B.V.
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study INCT02254915
Urinary Bladder...
Urologic Neopla...
Urogenital Neop...
Neoplasms
Neoplasms by Si...
Urinary Bladder...
Urologic Diseas...
Synergo + MMC
Bacillus Calmet...
18 Years - Medical Enterprises Europe B.V.
Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000).NCT05025930
Urologic Neopla...
endoscopic surg...
endoscopic surg...
18 Years - 80 YearsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesNCT04544748
Carcinoma, Non-...
Carcinoma, Rena...
Melanoma
GNR-051
18 Years - AO GENERIUM
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapyNCT04442724
Bladder Cancer
Urinary Bladder...
Urologic Neopla...
Neoplasms
Urinary Bladder...
Fiducial marker...
Multiparametric...
18 Years - Cedars-Sinai Medical Center
A Phase 1 Study of GNR-051 in Subjects With Advanced MalignanciesNCT04544748
Carcinoma, Non-...
Carcinoma, Rena...
Melanoma
GNR-051
18 Years - AO GENERIUM
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without RelatlimabNCT06237920
Urologic Neopla...
Urogenital Neop...
Neoplasms by Si...
Neoplasms
Female Urogenit...
Female Urogenit...
Urogenital Dise...
Urinary Bladder...
Male Urogenital...
Urinary Bladder...
Antineoplastics...
Nivolumab
Relatlimab
18 Years - The Netherlands Cancer Institute
JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinNCT01599013
Bladder Transit...
Vinflunine, Gem...
Vinflunine, Car...
18 Years - 79 YearsPierre Fabre Medicament
Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised SpecimenNCT05113134
Colorectal Neop...
Urologic Neopla...
Gastrointestina...
Neoplasms by Si...
Transvaginal na...
20 Years - Seoul National University Bundang Hospital
To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children SurgeryNCT05308771
Abdominal Herni...
Abdominal Wall ...
Abdominal Neopl...
Urogenital Dise...
Urologic Neopla...
Thoracic Diseas...
Lung Diseases
VPC syringe
- 16 YearsCentre Hospitalier Universitaire de Tivoli
Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer SurgeryNCT04630483
Cancer
Urologic Neopla...
Gynecologic Can...
INHA
TIVA
20 Years - 75 YearsMedipol University
Laparoscopic Partial Nephrectomy for cT1 TumorsNCT04213157
Renal Cancer
Renal Neoplasm
Renal Cell Carc...
Surgery
Surgery--Compli...
Renal Functiona...
Oncology
Oncology Proble...
Kidney Ischemia
Kidney Injury
Urologic Neopla...
Urologic Cancer
Kidney Neoplasm...
18 Years - 82 YearsSamsun Liv Hospital
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.NCT01398306
Carcinoma
Carcinoma, Rena...
Neuroendocrine ...
Carcinoid Tumor
Pancreatic Isle...
Blood sampling ...
18 Years - University Medical Center Groningen
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate CancerNCT00226954
Urologic Neopla...
zoledronic acid
18 Years - Stanford University
JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus CarboplatinNCT01599013
Bladder Transit...
Vinflunine, Gem...
Vinflunine, Car...
18 Years - 79 YearsPierre Fabre Medicament
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerNCT01454089
Urologic Neopla...
Metastatic Blad...
Urinary Tract N...
OGX-427 600 mg
OGX-427 1000 mg
Placebo
Gemcitabine
Cisplatin
Carboplatin
18 Years - Achieve Life Sciences
Pre-Operative Single Shot Rectus Sheath BlockNCT03458598
Bladder Neoplas...
Prostate Neopla...
Pelvic Neoplasm
Urologic Neopla...
Opioid Use
Anesthesia, Loc...
Pain, Postopera...
Rectus sheath b...
Bilateral rectu...
Patient control...
Subcutaneous in...
18 Years - University of Alberta
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate CancerNCT01155791
Urologic Neopla...
Prostate Cancer
Prostate Cancer...
Docetaxel
Biosyn
Prednisone
18 Years - Stanford University
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder CancerNCT03081858
Bladder Cancer ...
Non-Muscle Inva...
Bladder Cancer
Urinary Bladder
Transitional Ce...
Urinary Bladder...
Urologic Neopla...
Urogenital Neop...
Urinary Bladder...
Urologic Diseas...
TSD-001
18 Years - 85 YearsLipac Oncology LLC
LPN in Patients With High-complex Renal TumorsNCT04933604
Renal Cancer
Renal Neoplasm
Renal Cell Carc...
Surgery
Oncology
Kidney Ischemia
Kidney Injury
Urologic Neopla...
Urologic Cancer
Kidney Neoplasm...
laparoscopic pa...
Laparoscopic ra...
18 Years - 80 YearsSamsun Liv Hospital
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without RelatlimabNCT06237920
Urologic Neopla...
Urogenital Neop...
Neoplasms by Si...
Neoplasms
Female Urogenit...
Female Urogenit...
Urogenital Dise...
Urinary Bladder...
Male Urogenital...
Urinary Bladder...
Antineoplastics...
Nivolumab
Relatlimab
18 Years - The Netherlands Cancer Institute
Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck StudyNCT04702347
Urologic Cancer
Urologic Neopla...
Urine biomarker
18 Years - Fundacio Puigvert
Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive UropathyNCT04649970
Urologic Neopla...
Antegrade doubl...
- Université de Sousse
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaNCT02386111
Carcinoma, Rena...
Kidney Diseases
Kidney Neoplasm...
Urogenital Neop...
Urologic Diseas...
Urologic Neopla...
Neoplasms
Neoplasms by Hi...
Clear-cell Meta...
Combination of ...
18 Years - Celldex Therapeutics
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerNCT03288545
Carcinoma, Tran...
Urinary Bladder...
Urologic Neopla...
Renal Pelvis Ne...
Urothelial Canc...
Ureteral Neopla...
Urethral Neopla...
enfortumab vedo...
pembrolizumab
cisplatin
carboplatin
gemcitabine
18 Years - Astellas Pharma Inc
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)NCT04922047
Urinary Bladder...
Urologic Neopla...
Urogenital Neop...
Antineoplastic ...
Urinary Bladder...
Tislelizumab An...
tislelizumab an...
18 Years - 75 YearsRenJi Hospital
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder CancerNCT01200992
Bladder Neoplas...
Neoplasm Recurr...
Transitional Ce...
Carcinoma in Si...
Mycobacterium
EN3348
Mitomycin C
18 Years - Bioniche Life Sciences Inc.
Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer SurgeryNCT04630483
Cancer
Urologic Neopla...
Gynecologic Can...
INHA
TIVA
20 Years - 75 YearsMedipol University
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerNCT01454089
Urologic Neopla...
Metastatic Blad...
Urinary Tract N...
OGX-427 600 mg
OGX-427 1000 mg
Placebo
Gemcitabine
Cisplatin
Carboplatin
18 Years - Achieve Life Sciences
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the BladderNCT01310803
Carcinoma in Si...
Transitional Ce...
Non-muscle Inva...
VALSTAR - Maint...
No Maintenance ...
18 Years - Endo Pharmaceuticals
Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell CarcinomaNCT04644432
Metastatic Rena...
Kidney Neoplasm
Urologic Neopla...
Urogenital Neop...
Medication (A s...
Patient reporte...
18 Years - Herlev and Gentofte Hospital
Evaluation of NanoDoce® in Participants With Urothelial CarcinomaNCT03636256
Bladder Cancer
Urothelial Carc...
Urinary Bladder...
Urinary Bladder...
Urogenital Neop...
Urologic Neopla...
Urologic Cancer
Malignant Tumor...
Cancer of the B...
NanoDoce (direc...
NanoDoce (intra...
Institutional S...
NanoDoce (intra...
18 Years - NanOlogy, LLC
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)NCT05935748
ccRCC
Clear Cell Rena...
Kidney Cancer
Kidney Neoplasm...
Renal Cancer
Renal Neoplasms
Recurrent Renal...
Metastatic Rena...
Refractory Rena...
Advanced Renal ...
Carcinoma
Neoplasms
Carcinoma, Rena...
Neoplasms, Glan...
Neoplasm by His...
Adenocarcinoma
Urologic Neopla...
Urogenital Neop...
Neoplasms by Si...
Kidney Diseases
Urologic Diseas...
NKT2152
palbociclib
sasanlimab
18 Years - NiKang Therapeutics, Inc.
Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial CancerNCT04052113
Urologic Neopla...
- AstraZeneca
A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)NCT01799499
Non Muscle Inva...
TC-3 hydrogel
TC-3 hydrogel
TC-3 hydrogel
21 Years - UroGen Pharma Ltd.
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder CancerNCT05241340
Urothelial Carc...
Sasanlimab
Stereotactic Bo...
Radical Cystect...
18 Years - The Methodist Hospital Research Institute
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaNCT04300140
Clear Cell Rena...
Batiraxcept
Cabozantinib (C...
Nivolumab
18 Years - Aravive, Inc.
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell CarcinomaNCT01339975
Carcinoma
Carcinoma Renal...
Kidney Neoplasm...
Kidney Diseases
Chemokines
Biological samp...
Biological samp...
18 Years - University Hospital, Bordeaux
Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Kidney SpecimenNCT05135520
Urologic Neopla...
Transvaginal na...
Transabdominal ...
20 Years - Seoul National University Bundang Hospital
LPN in Patients With High-complex Renal TumorsNCT04933604
Renal Cancer
Renal Neoplasm
Renal Cell Carc...
Surgery
Oncology
Kidney Ischemia
Kidney Injury
Urologic Neopla...
Urologic Cancer
Kidney Neoplasm...
laparoscopic pa...
Laparoscopic ra...
18 Years - 80 YearsSamsun Liv Hospital
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestNCT05899361
Urologic Cancer
Urologic Neopla...
Bladder Cancer
Prostate Cancer
Testicular Canc...
Kidney Cancer
Urethral Cancer
Penile Cancer
Electromagnetic...
Ultrasound
18 Years - Dana-Farber Cancer Institute
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC PatientsNCT02307487
Bladder Cancer
Neoplasms
Urinary Bladder...
Urologic Diseas...
120 mg MMC in 9...
140 mg MMC in 9...
160 mg MMC in 9...
120 mg MMC in 6...
140 mg MMC in 6...
160 mg MMC in 6...
18 Years - UroGen Pharma Ltd.
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study INCT02254915
Urinary Bladder...
Urologic Neopla...
Urogenital Neop...
Neoplasms
Neoplasms by Si...
Urinary Bladder...
Urologic Diseas...
Synergo + MMC
Bacillus Calmet...
18 Years - Medical Enterprises Europe B.V.
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaNCT04300140
Clear Cell Rena...
Batiraxcept
Cabozantinib (C...
Nivolumab
18 Years - Aravive, Inc.
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC PatientsNCT02891460
Urinary Bladder...
Urologic Neopla...
Neoplasms
Urinary Bladder...
Urologic Diseas...
40 mg MMC in 40...
80 mg MMC in 40...
18 Years - UroGen Pharma Ltd.
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestNCT05899361
Urologic Cancer
Urologic Neopla...
Bladder Cancer
Prostate Cancer
Testicular Canc...
Kidney Cancer
Urethral Cancer
Penile Cancer
Electromagnetic...
Ultrasound
18 Years - Dana-Farber Cancer Institute
Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the UrotheliumNCT00034177
Urologic Neopla...
S-8184 Paclitax...
Experimental Ar...
18 Years - Achieve Life Sciences
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumNCT00034593
Urologic Neopla...
ALIMTA
gemcitabine
18 Years - Eli Lilly and Company
LPN in Patients With High-complex Renal TumorsNCT04933604
Renal Cancer
Renal Neoplasm
Renal Cell Carc...
Surgery
Oncology
Kidney Ischemia
Kidney Injury
Urologic Neopla...
Urologic Cancer
Kidney Neoplasm...
laparoscopic pa...
Laparoscopic ra...
18 Years - 80 YearsSamsun Liv Hospital
Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive UropathyNCT04649970
Urologic Neopla...
Antegrade doubl...
- Université de Sousse
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)NCT00753415
Non-Small Cell ...
Breast Cancer
Melanoma
Upper GI Tract ...
Colon Carcinoma
Renal Cell Carc...
Bladder Carcino...
Prostate Cancer
V935
V934-EP
18 Years - Merck Sharp & Dohme LLC
Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck StudyNCT04702347
Urologic Cancer
Urologic Neopla...
Urine biomarker
18 Years - Fundacio Puigvert
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsNCT04579380
Uterine Neoplas...
Uterine Cervica...
Biliary Tract N...
Urologic Neopla...
Carcinoma, Non-...
HER2 Mutations ...
tucatinib
trastuzumab
fulvestrant
18 Years - Seagen Inc.
Laparoscopic Partial Nephrectomy for cT1 TumorsNCT04213157
Renal Cancer
Renal Neoplasm
Renal Cell Carc...
Surgery
Surgery--Compli...
Renal Functiona...
Oncology
Oncology Proble...
Kidney Ischemia
Kidney Injury
Urologic Neopla...
Urologic Cancer
Kidney Neoplasm...
18 Years - 82 YearsSamsun Liv Hospital
Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerNCT00151034
Urologic Neopla...
Trastuzumab
Paclitaxel
Carboplatin
Gemcitabine
18 Years - University of Michigan Rogel Cancer Center
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumNCT00034593
Urologic Neopla...
ALIMTA
gemcitabine
18 Years - Eli Lilly and Company
A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerNCT02543645
Carcinoma, Rena...
Kidney Diseases
Kidney Neoplasm...
Urogenital Neop...
Urologic Diseas...
Urologic Neopla...
Neoplasms by Hi...
Neoplasms
Clear-cell Meta...
Melanoma
Triple Negative...
Bladder Cancer
Head and Neck C...
Non-small Cell ...
Combination of ...
18 Years - Celldex Therapeutics
Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial CancerNCT04052113
Urologic Neopla...
- AstraZeneca
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCCNCT06114940
Neoplasms
Kidney Neoplasm...
Urologic Neopla...
Urogenital Neop...
Female Urogenit...
Urogenital Dise...
Kidney Diseases
Urologic Diseas...
Male Urogenital...
Carcinoma
Carcinoma, Rena...
Antineoplastic ...
Immune Checkpoi...
Toripalimab
Lenvatinib
18 Years - Jinling Hospital, China
Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic NeoplasmsNCT05990621
CD70-positive A...
Anti-CD70 CAR-T...
18 Years - Changhai Hospital
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the BladderNCT01310803
Carcinoma in Si...
Transitional Ce...
Non-muscle Inva...
VALSTAR - Maint...
No Maintenance ...
18 Years - Endo Pharmaceuticals
Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000).NCT05025930
Urologic Neopla...
endoscopic surg...
endoscopic surg...
18 Years - 80 YearsSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCCNCT06114940
Neoplasms
Kidney Neoplasm...
Urologic Neopla...
Urogenital Neop...
Female Urogenit...
Urogenital Dise...
Kidney Diseases
Urologic Diseas...
Male Urogenital...
Carcinoma
Carcinoma, Rena...
Antineoplastic ...
Immune Checkpoi...
Toripalimab
Lenvatinib
18 Years - Jinling Hospital, China
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: